Memorial Sloan Kettering is offering a one-year clinical fellowship in complex thoracic surgery for individuals who will have completed a cardiothoracic training program by July of 2027 and are interested in an advanced experience in thoracic surgical oncology. Applicants should be board-certified or board-eligible, or the equivalent, by July 2027. Applicants from outside of the U.S. are welcome but must hold a valid ECFMG certificate. Practicing cardiothoracic surgeons may also be eligible.
Our internationally-renowned faculty is composed of fourteen thoracic surgeons, all of whom share a strong belief in the importance of mentorship and teaching that serves as the foundation for our training program. Fellows enjoy a broad exposure to a variety of both malignant and benign pathology, and an emphasis is placed on the multidisciplinary management of thoracic cancers. Minimally invasive, including VATS, robotic and advanced endoscopic techniques are equally emphasized alongside complex open surgical approaches. Experience in the clinic is integral to the fellow’s training as well and offers a robust experience in the evaluation of patients being considered for surgical management. A highly structured didactic program complements an extensive operative experience which is second to none, and fellows have ample opportunity to pursue clinical research and academic scholarship.
Deadline
September 30, 2026
Length of Program
1 year (August 1, 2027 – July 31, 2028)
Eligibility
US applicants must have completed their training in cardiothoracic surgery by the time they begin the fellowship and be Board-certified or Board-eligible. Foreign medical graduates who hold a valid ECFMG certificate and who have completed their training in cardiothoracic surgery are also eligible to apply.
Number of Positions
2
How to Apply
Memorial Sloan Kettering Cancer Center is a participant in The Fellowship Council Matching Program. Applicants are required to complete an application through The Fellowship Council.
Memorial Sloan Kettering Cancer Center — the world’s oldest and largest private cancer center — has devoted more than 130 years to exceptional patient care, innovative research, and outstanding educational programs. Today, we are one of 50 National Cancer Institute–designated Comprehensive Cancer Centers, with state-of-the-art science flourishing side by side with clinical studies and treatment.
The close collaboration between our physicians and scientists is one of our unique strengths, enabling us to provide patients wi...